British scientists behind key COVID-19 trial launch study to test monkeypox treatment - CNA

LONDON: The British scientists behind one of the major therapeutic COVID-19 trials have turned their focus to treatments for monkeypox, a viral disease that has been labeled a global health emergency by the

SIGA's drug, branded TPOXX, has been cleared to treat diseases caused by the family of orthopoxvirus that includes smallpox, monkeypox and cowpox by the European Union and UK, but due to limited tria… [+1688 chars]

full article...